Objective: Promotion of endogenous b-cell mass expansion could facilitate regeneration in patients with diabetes. We discovered that the secreted protein CTGF (aka CCN2) promotes adult b-cell replication and mass regeneration after injury via increasing b-cell immaturity and shortening the replicative refractory period. However, the mechanism of CTGF-mediated b-cell proliferation is unknown. Here we focused on whether CTGF alters cells of the immune system to enhance b-cell replication. Methods: Using mouse models for 50% b-cell ablation and conditional, b-cell-specific CTGF induction, we assessed changes in immune cell populations by performing immunolabeling and gene expression analyses. We tested the requirement for macrophages in CTGF-mediated b-cell proliferation via clodronate-based macrophage depletion.
INTRODUCTION
Connective Tissue Growth Factor (CTGF/CCN2), a member of the CCN family of secreted extracellular matrix (ECM)-associated proteins, is a b-cell proliferative factor [1e3] . Although CTGF induction in adult b-cells does not increase proliferation [4] , CTGF treatment after 50% b-cell ablation promotes b-cell proliferation and regeneration by modifying b-cell intrinsic characteristics, including maturity state and replication refractory period [2] . We hypothesized that CTGF induction might also elicit b-cell mass regeneration by altering extrinsic factors of the islet micro-environment, in particular immune cell populations. In other models of tissue damage, CTGF promotes wound repair via immune cell modulation [5] . For example, in the kidney, CTGF induction promoted infiltration of both macrophages and T cells [6] , suggesting that CTGF serves as an immune cell chemoattractant. Further, in an ethanol model of pancreatic injury, CTGF over-expression increased recruitment of neutrophils and T-cells to the pancreas [7] . CTGF may thus promote the recruitment of particular immune cell populations and/or alter their characteristics, resulting in increased b-cell proliferation and regeneration.
The role of the immune system in b-cell regeneration is wellappreciated [8e10]. Specifically, macrophages are critical for proper b-cell mass regeneration after injury by partial duct ligation [10] and VEGF-mediated islet endothelial cell expansion [9] . Additionally, several groups have proposed that T cells promote b-cell mass regeneration in the setting of diabetes mellitus [8, 11] . Following 50% b-cell ablation, we observed an increase in macrophages, which was further heightened by CTGF induction after b-cell destruction. In addition, we observed an increase in T cells in the parenchyma only in pancreata from animals with CTGF induction after 50% b-cell ablation.
Whole islet gene expression analysis revealed that CTGF induction after b-cell ablation increased the expression of several markers of M1 macrophages and T cells as well as chemoattractant genes. Thus, it appears that CTGF induction after 50% b-cell ablation promotes an increase in both T cells and macrophages.
We assessed the requirement for macrophages in CTGF-mediated bcell regeneration via macrophage depletion. We observed that a reduction in macrophages (with no changes in T cell number) in this model of b-cell destruction inhibits the proliferative effects elicited by CTGF induction. Also, we propose that macrophage depletion, promotes a more mature b-cell phenotype, via an unknown mechanism, contributing to the inability of b-cells to proliferate in response to CTGF.
Together these data suggest a critical role for macrophages during CTGF-mediated b-cell proliferation and regeneration.
MATERIALS AND METHODS

Animals
Generation of RIP-rtTA [12] , TetO-CTGF [1] , and RIP-DTR [13] transgenic mice has been described previously. Primers are available upon request. Female mice were administered 2 mg/ml of doxycycline (DOX) in 2% Splenda (to avoid taste aversion) in drinking water after diphtheria toxin (DT) administration. Mice were treated with DOX for 2 days. DT (126 ng; Sigma) was given I.P. three times at 8 weeks of age. PBSor clodronate-liposomes (250 mL; clodronateliposomes.com) were given I.P. once a day for 8 days. Liposomes (artificially prepared lipid vesicles) contained either PBS or clodrinate, a non-toxic bisphosphonate. After injection, liposomes are ingested and digested by macrophages. Clodronate is released and accumulates intracellularly, where at high intracellular concentrations, it induces apoptosis [14] . These studies were all approved by the Vanderbilt University Institutional Animal Care and Use Committee.
Immunolabeling
Pancreata were dissected and fixed for 1 h in 4% paraformaldehyde at 4 C, and placed in a 30% sucrose solution overnight at 4 C. Pancreata were embedded in O.C.T. (Tissue-Tek) and serial sectioned on a cryostat at 7 mM. Indirect protein localization was obtained by incubations with primary antibodies overnight at 4 C: Guinea Pig a-Insulin (DAKO; 1:500), Rabbit a-Ki67 (AbCam; 1:500), Rabbit a-MafA (Bethyl Laboratories; 1:400), Rat a-CD45 (BD Pharmingen; 1:100), Rat a-F4/80 (Invitrogen; 1:100), Rat a-B220 (BD Pharmingen; 1:100), Rat a-CD3 (BD Pharmingen; 1:00). Nuclei were visualized with DAPI (Molecular Probes). Immunohistochemistry for Neutrophil Marker (Sigma) was completed by Vanderbilt University's Translational Pathology Shared Resource. Imaging was with a ScanScope FL scanner (Aperio Technologies, Inc.) and quantified using Metamorph 6.1 (Molecular Devices). Unless otherwise noted, 4 sections more than 250 mM apart were selected and immunolabeled, with !4,000 cells per animal quantified. 
Gene expression analysis
Islets were isolated from 10 week old females and immediately prepared for RNA isolation by dissolving in Trizol reagent. RNA was isolated using the RNeasy Mini kits (Qiagen). Greater than 250 ng cDNA was prepared from islet RNA using the SuperScript III First Stand Synthesis System (Invitrogen). TLDAs were conducted on a 7900HT Fast Real-Time PCR system. Data was analyzed with SDS RQ Study software (Applied Biosystems, Life Technologies). cDNA for qRT-PCR was generated using the iScript cDNA synthesis kit (BioRad 
RESULTS
CTGF induction increases islet-associated macrophages and T cells at the peak of b-cell proliferation
We previously showed that CTGF promotes b-cell mass regeneration, without altering a-cell proliferation or number [2] . This was achieved by using a diphtheria toxin (DT)-mediated mouse model (RIP-DTR) of 50% b-cell ablation paired with our previously described b-cell specific doxycycline (Dox)-inducible CTGF bi-transgenic model (RIP-rtTA;
TetO-CTGF) [1, 4, 13] . This model of b-cell ablation does not result in alterations in glucose homeostasis [2] . At 8 weeks of age, DT was administered to RIP-DTR; RIP-rtTA controls ("Ablation") and RIP-DTR; RIP-rtTA; TetO-CTGF experimental animals ("Ablation þ CTGF") and CTGF induced for 2 days ( Figure 1A ). This time was chosen as it is the peak of b-cell proliferation in Ablation þ CTGF pancreata [2] . Non-DT Figure 1A ,CeF), were observed within the pancreatic parenchyma of any cohort, and rarely were they observed close to islets (Supplemental Figure 1B ,C-F) Additionally, as CTGF has been shown to recruit neutrophils in other models of pancreatic injury, we assessed this immune population via immunohistochemistry (Supplemental Figure 1IeL) .
However, in our model of b-cell ablation, no significant increase of neutrophils was observed (Supplemental Figure 1GeL) . Finally, we observed no presence of eosinophils, as assessed by H&E staining, in any cohort (not shown).
Gene expression analyses reveal changes associated with increased macrophages and T cells
To gain further insight into which immune cell populations and associated signaling pathways are altered by CTGF with or without bcell ablation, gene expression analysis was conducted on islets isolated from animals following 2 days of CTGF induction in vivo. We specifically assessed changes in expression of genes associated with the innate and adaptive immune cell response, including cytokine expression changes (Figure 3 ; Supplemental Figure 2A ). In addition, gene expression alterations in ECM components, vascular markers, and the stress response were determined (Supplemental Figure 2B ,C). There were several changes in key innate and adaptive immune response genes following ablation and/or CTGF induction ( Figure 3A,B) .
CTGF induction under normal conditions or after b-cell ablation elicited an increase in Mcp1 (Macrophage Chemoattractant Protein 1), RANTES (Regulated on Activation, Normal T cell Expressed and Secreted/CCL5), and Ccr2 (CeC chemokine receptor type 2). MCP1 and its receptor, Ccr2, serve as chemoattractants for macrophages [15, 16] , in agreement with the immunolabeling results showing increased macrophages in islets. In addition, RANTES promotes macrophage activation along with T cell recruitment [17] , further corroborating the observed increase in T cells in our Ablation þ CTGF cohort. b-cell ablation alone and in conjunction with CTGF induction increased expression of CD45, a pan-leukocyte marker, and CD68, a macrophage marker, once again aligning with immunolabeling findings. These results were highly suggestive of a critical role for macrophages in CTGF-mediated b-cell proliferation. The unique setting of CTGF induction after b-cell ablation resulted in the specific upregulation of C3 (Complement Component 3), TNFa (Tissue Necrosis Factor a), and Selp (Selectin P). These genes are all associated with inflammation [18, 19] , while Selp also serves as a leukocyte chemoattractant [20] . Alterations in expression of genes associated with the adaptive immune response focused primarily on T cells ( Figure 3B ). CTGF induction under normal conditions did not promote the expression of any genes associated with the adaptive immune response ( Figure 3B ).
However, b-cell ablation alone or with CTGF induction increased the expression of CD3e, a marker of T cells, and Stat4, a promoter of Th 1 development (Figure 3B ; Ablation; [21] ). Expression of several genes was increased only in the Ablation þ CTGF cohort ( Figure 3B ; Ablation þ CTGF). These included several additional markers of T cells, including CD4 (T helper cells), CD28 (costimulator necessary for T cell activation), and CD8a (Cytotoxic T cells). Additionally, CTGF induction after b-cell ablation elicited the increased expression of macrophageexpressed genes that promote T cell activation (CD86) and trafficking (Ccl19) [22, 23] . Finally, CTGF induction alone promoted the expression of Ctla4 (Cytotoxic T Lymphocyte Associated protein 4), which downregulates T cell activation [24] (Figure 3A) . As predicted by immunolabeling, we did not observe changes in expression of genes associated with B cells (Figure 3B , CD19, CD40, CD38). We also assessed changes in the expression of several cytokines (Supplemental Figure 2A) . However, the only observed alteration was with IL-12b (Interluekin-12b), which was induced by CTGF expression after b-cell ablation and under normal settings (Supplemental Figure 2A) . IL-12b is expressed by macrophages and aids T helper cell development [25] . Overall, these findings align well with our observed increase in T cells in the Ablation þ CTGF cohort ( Figure 2I Finally, we assessed alterations to genes associated with the ECM and vasculature, which play key roles in immune cell trafficking (Supplemental Figure 2B ). In our model Vcam1 (Vascular Cell Adhesion Molecule 1) was the sole gene significantly upregulated, and only with CTGF induction after b-cell ablation (Supplemental Figure 2B) . Vcam1 is critical for adhesion of leukocytes to endothelial cells and subsequent signal transduction, leading to extravasation [26] . Increased Vcam1 expression, suggested to us that the increase in macrophages was due to increased extravasation from the pancreatic vasculature.
As an alternative, we examined whether CTGF increased macrophage proliferation, but failed to detect any proliferating macrophages (Supplemental Figure 3) . Thus, increased macrophage recruitment, rather than proliferation of resident pancreatic macrophages in response to CTGF, appears to cause the increase in islet-associated macrophages in our model.
We also assessed whether our model of CTGF mediated b-cell regeneration involved induction or alterations to the cellular stress response (Supplemental Figure 2C) . However, no alterations were observed. Thus, it appears that in CTGF-mediated b-cell mass expansion after b-cell ablation, CTGF induction promotes an increase in and activation of primarily macrophages and T cells. li i u uli ul u u n n n n n n n n n n n n n n n n n n n n n n n n n n n n CD4 CD4 injected with PBS-containing liposomes in which CTGF was induced ("Ablation þ CTGF þ PBS") ( Figure 4A ). F4/80 immunolabeling confirmed clodronate induction-specific depletion of macrophages ( Figure 4B ). Additionally, since macrophages can serve as T cell chemoattractors [27] , we assessed whether removal of macrophages also decreased the observed increase in T cells in our "Ablation þ CTGF" cohort ( Figure 2I ). However, clodronate liposome treatment does not result in a decrease in pancreatic T cells ( Figure 4C ). Thus, we were able to assess the macrophage-specific effects on CTGF-mediated b-cell proliferation. CTGF induction elicits b-cell regeneration by increasing b-cell proliferation [2] . Thus, we assessed whether the increase of macrophages B. 
DISCUSSION
In other pancreatic injury models, CTGF recruits immune cells to the site of injury [7] . Here we investigated the potential role of the immune system in CTGF-mediated b-cell proliferation after partial b-cell macrophages are involved in b-cell mass regeneration following injury [9, 10] . However, our study is the first to our knowledge, to utilize a bcell-specific injury model and is the first to link a specific b-cell proliferative factor to increased macrophage numbers and enhanced bcell proliferation. We considered the possibility that a fraction of proliferating insulinpositive cells were actually proliferating macrophages that had engulfed b-cells. However, we failed to detect any proliferating macrophages nor did we observe any cells co-labeled with insulin and F4/80, arguing against this idea. Additionally, gene expression analysis showed that CTGF induction specifically increased expression of several macrophage markers and macrophage chemoattractant genes. Several genes (CD86, Ccl19, IL-12b) associated with the pro-inflammatory M1 macrophage polarization phenotype were increased in the setting of CTGF induction after b-cell destruction. Likewise, preliminary qRT-PCR data showed a highly significant decrease in Arg1 expression, a gene associated with M2 macrophage polarization, in islets from Ablation þ CTGF mice compared to Control islets (not shown). Mgl1 and Chil3, two other genes associated with M2 macrophage polarization, also displayed a trend towards decreased expression in Ablation þ CTGF samples compared to Ablation alone (not shown). Further studies are needed to fully characterize the macrophage polarization phenotype in this model of b-cell regeneration.
The increase in T cells specifically in the setting of CTGF induction after b-cell destruction was not unexpected, as studies have proposed that T cells promote b-cell mass regeneration in the setting of diabetes mellitus [8, 11] . Also, CTGF promotes T cell recruitment in the kidney [6] . Gene expression analysis on whole islets corroborated our immunofluorescence findings as upregulation of several T cell markers and chemoattractant genes was observed in the Ablation þ CTGF cohort. While several of the T cell marker genes pointed towards a T helper cell population, further studies are needed to determine the specific T cell sub-population(s) involved in CTGF-mediated b-cell We propose a potential model on how CTGF promotes b-cell mass expansion ( Figure 4F ). An increase in macrophages is observed following b-cell destruction. However, these macrophages alone are unable to promote b-cell proliferation. We hypothesize that CTGF induction increases the number of islet-associated macrophages, thus elevating the levels of an as yet unidentified factor above a required threshold to allow for b-cell responsiveness ( Figure 4F ). CTGFmediated macrophage recruitment alters the islet microenvironment to become more responsive to proliferative stimuli. We propose four potential candidates for this proliferative stimulus (Figure 4 ): 1) CTGF itself, 2) other proliferative factors induced by CTGF (i.e. Hepatocyte Growth Factor (HGF), Serotonin (5-HT), Integrin b1, [2] ), 3) an endogenous macrophage-derived factor or 4) a novel macrophagederived factor induced by CTGF. In other words, CTGF could affect the concentration of a factor or the type of factor being produced. The relevance of CTGF to human patients with diabetes and diabetic animal models remains unknown. A gene expression analysis reported by Keller et al., found a reduction in Ctgf expression in islets from 4 week old but not 10 week old non-diabetic ob/ob animals compared with controls [28] . The relationship between the difference in CTGF expression and the impact it had on b-cell proliferation is not clear. CTGF mediated b-cell mass proliferation involves the modification of several b-cell intrinsic characteristics. We now show that the immune system, specifically macrophages, is also required for effective CTGFmediated b-cell mass expansion following injury. We have identified a novel interaction between CTGF and the immune system to promote b-cell proliferation and thus, regeneration. As all forms of diabetes are demarked by both inflammation and insufficient functional b-cell mass, our studies highlight the significance of understanding the role of the immune system in promoting b-cell regeneration.
